Apple's recent quarterly check-ins have been fairly ho-hum, but not this time! The Mac maker is back to growth after an impressive quarter, we explain what segments pushed the company over the top, and what investors can expect next quarter.

Forget that power plant off in the distance, these places have wind mills present on the horizon.

Forget that power plant off in the distance, these places have wind mills present on the horizon.

Competitors make headway against Teva Pharmaceutical's top-seller, and Biogen's hemophilia drugs become Bioverativ. Here's what you should know.

Competitors make headway against Teva Pharmaceutical's top-seller, and Biogen's hemophilia drugs become Bioverativ. Here's what you should know.

Will Airbnb launch its IPO in 2017? Is Macau officially on track for a recovery? Will Japan eventually become the new casino capital of the world? Fool.com contributor Seth McNew shares his insights after traveling through the regio

Will Airbnb launch its IPO in 2017? Is Macau officially on track for a recovery? Will Japan eventually become the new casino capital of the world? Fool.com contributor Seth McNew shares his insights after traveling through the regio

Use these tips to get out of debt and make the most of your credit.

Use these tips to get out of debt and make the most of your credit.

It's earnings season, so we're breaking down quarterly results from two Fool favorites, Alphabet and Paypal. We hit the headline numbers, key metrics, and dig through management's comments to catch all the info investors need to know.